Identification of DOK genes as lung tumor suppressors (original) (raw)

• Carpino, N. et al. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88, 197–204 (1997).
  Article CAS PubMed Google Scholar
• Yamanashi, Y. & Baltimore, D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 88, 205–211 (1997).
  Article CAS PubMed Google Scholar
• Di Cristofano, A. et al. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J. Biol. Chem. 273, 4827–4830 (1998).
  Article CAS PubMed Google Scholar
• Cong, F., Yuan, B. & Goff, S.P. Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol. Cell. Biol. 19, 8314–8325 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Grimm, J. et al. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J. Cell Biol. 154, 345–354 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Crowder, R.J., Enomoto, H., Yang, M., Johnson, E.M. Jr. & Milbrandt, J. Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth. J. Biol. Chem. 279, 42072–42081 (2004).
  Article CAS PubMed Google Scholar
• Okada, K. et al. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312, 1802–1805 (2006).
  Article CAS PubMed Google Scholar
• Yamanashi, Y. et al. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev. 14, 11–16 (2000).
  CAS PubMed PubMed Central Google Scholar
• Di Cristofano, A. et al. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J. Exp. Med. 194, 275–284 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, N. & Dumont, D.J. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation. Curr. Biol. 9, 1057–1060 (1999).
  Article CAS PubMed Google Scholar
• Suzu, S. et al. p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction. EMBO J. 19, 5114–5122 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Zhao, M., Janas, J.A., Niki, M., Pandolfi, P.P. & Van Aelst, L. Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis. Mol. Cell. Biol. 26, 2479–2489 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Yasuda, T. et al. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J. Exp. Med. 200, 1681–1687 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Niki, M. et al. Role of Dok-1 and Dok-2 in leukemia suppression. J. Exp. Med. 200, 1689–1695 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lau, S.K., Luthringer, D.J. & Eisen, R.N. Thyroid transcription factor-1: a review. Appl. Immunohistochem. Mol. Morphol. 10, 97–102 (2002).
  CAS PubMed Google Scholar
• Al-Hajj, M. & Clarke, M.F. Self-renewal and solid tumor stem cells. Oncogene 23, 7274–7282 (2004).
  Article CAS PubMed Google Scholar
• Dick, J.E. & Lapidot, T. Biology of normal and acute myeloid leukemia stem cells. Int. J. Hematol. 82, 389–396 (2005).
  Article CAS PubMed Google Scholar
• Kim, C.F. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823–835 (2005).
  Article CAS PubMed Google Scholar
• Chitale, D. et al. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene 28, 2773–2783 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Weir, B.A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893–898 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wistuba, I.I. et al. Allelic losses at chromosome 8p21–23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 59, 1973–1979 (1999).
  CAS PubMed Google Scholar
• Ohata, H. et al. Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosom. Cancer 7, 85–88 (1993).
  Article CAS PubMed Google Scholar
• Rhodes, D.R. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1–6 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Su, L.J. et al. Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics 8, 140 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Stearman, R.S. et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am. J. Pathol. 167, 1763–1775 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Jackson, E.L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243–3248 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Pei, X.H., Bai, F., Smith, M.D. & Xiong, Y. p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers. Cancer Res. 67, 3162–3170 (2007).
  Article CAS PubMed Google Scholar
• Yanagi, S. et al. Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J. Clin. Invest. 117, 2929–2940 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ventura, J.J. et al. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39, 750–758 (2007).
  Article CAS PubMed Google Scholar
• Yasuda, T. et al. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling. Int. Immunol. 19, 487–495 (2007).
  Article CAS PubMed Google Scholar
• Shinohara, H. et al. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. J. Exp. Med. 201, 333–339 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ng, C.H., Xu, S. & Lam, K.P. Dok-3 plays a nonredundant role in negative regulation of B-cell activation. Blood 110, 259–266 (2007).
  Article CAS PubMed Google Scholar
• Inoue, A., Yasuda, T., Yamamoto, T. & Yamanashi, Y. Dok-1 is a positive regulator of IL-4 signalling and IgE response. J. Biochem. 142, 257–263 (2007).
  Article CAS PubMed Google Scholar
• Kashiwada, M. et al. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5′-phosphatase are required for regulation of CD4+CD25+ T cell development. J. Immunol. 176, 3958–3965 (2006).
  Article CAS PubMed Google Scholar
• Tonon, G. et al. High-resolution genomic profiles of human lung cancer. Proc. Natl. Acad. Sci. USA 102, 9625–9630 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Fujiwara, Y. et al. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res. 53, 1172–1174 (1993).
  CAS PubMed Google Scholar
• Emi, M. et al. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res. 52, 5368–5372 (1992).
  CAS PubMed Google Scholar
• Macoska, J.A. et al. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res. 55, 5390–5395 (1995).
  CAS PubMed Google Scholar
• Scholnick, S.B. et al. Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx. J. Natl. Cancer Inst. 88, 1676–1682 (1996).
  Article CAS PubMed Google Scholar
• Dobbin, K.K. et al. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin. Cancer Res. 11, 565–572 (2005).
  CAS PubMed Google Scholar
• Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. & Pandolfi, P.P. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179–193 (2005).
  Article CAS PubMed Google Scholar